Innovations, technologies and methodologies in driving drug discovery developme across Asia
Dr. Shinichi Koizumi | SVP, Research & CSO RaQualia Pharma
Shinichi Koizumi, Ph.D. has experience in drug discovery more than 20 years and is one of founders of RaQualia and currently serving as Head of Research and CSO. Before starting RaQualia Shinichi was responsible as Head of Biology in Pfizer Central Research Laboratories at Nagoya and contributed producing several development candidates in the field of Pain, Gastro Intestinal Diseases. Shinichi joined Ciba-Geigy in 1989 and after the merger with Sandoz, he became a Head of Biology in Novartis Tsukuba Research Institute and contributed to the drug discovery research in the various therapeutic areas such as neuroscience, oncology, metabolic diseases, pain etc...
Share this
Appearances at this years' conference:
Conference Day 2: 21 March 2012
@ 09.35
An R&D strategy to achieving “proof of value”
Finding the best approach and key valuation parameter for R&D projects
Differentiating between novel, first in class therapies and other projects at other R&D stages
Application of RaQualia’s “proof of value” business model for effective licensing with partners
› Dr. Shinichi Koizumi, SVP, Research & CSO, RaQualia Pharma